Clinical and neuropsychological correlates of the P300 in schizophrenia

被引:50
|
作者
Nieman, DH
Koelman, JHTM
Linszen, DH
Bour, LJ
Dingemans, PM
de Visser, BWO
机构
[1] Acad Med Ctr, Dept Psychiat, NL-1105 BC Amsterdam, Netherlands
[2] Acad Med Ctr, Dept Neurol, Clin Neurophysiol Unit, NL-1105 BC Amsterdam, Netherlands
关键词
recent-onset schizophrenia; P300 event-related potential; neuropsychology; antipsychotic medication;
D O I
10.1016/S0920-9964(01)00184-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We investigated the relationship between the P300, neuropsychological test performance and symptomatology in recentonset schizophrenic patients (n = 45) to gain insight into underlying mechanisms of abnormal P300 in schizophrenia. The P300 was recorded in two sessions with an intermission of five minutes, at the midline frontal, central and parietal electrode site. P300 amplitude and latency were compared with those obtained in 25 controls. Twenty patients were treated with olanzapine and 19 patients with risperidone. P300 amplitude was smaller and latency longer in patients than in controls. In the patient group, parietal P300 amplitude reduction was related to poorer performance on neuropsychological tests of memory. Frontal P300 amplitude reduction was related to impaired selective attention. In patients with negative symptomatology. P300 amplitude was reduced in the second P300 session compared with the first. Patients on risperidone demonstrated a smaller parietal P300 amplitude than patients using olanzapine. Reduced parietal P300 amplitude could signify a dysfunction in the continuous memory updating of cur-rent events. Negative symptomatology may be associated with a time dependent decrease in neuronal firing. as indicated by reduced P300 amplitude in the second P300 session. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 50 条
  • [21] P300 IN FAMILIAL AND NONFAMILIAL SCHIZOPHRENIA
    FRANGOU, S
    ALARCON, G
    SHARMA, T
    TAKEI, N
    BINNIE, C
    MURRAY, RM
    SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 159 - 159
  • [22] P300 and genetic risk for schizophrenia
    Winterer, G
    Egan, MF
    Raedler, T
    Sanchez, C
    Jones, DW
    Coppola, R
    Weinberger, DR
    ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (11) : 1158 - 1167
  • [23] P300 and symptom improvement in schizophrenia
    Gallinat, J
    Riedel, M
    Juckel, G
    Sokullu, S
    Frodl, T
    Moukhtieva, R
    Mavrogiorgou, P
    Nisslé, S
    Müller, N
    Danker-Hopfe, H
    Hegerl, U
    PSYCHOPHARMACOLOGY, 2001, 158 (01) : 55 - 65
  • [24] ALTERED P300 TOPOGRAPHY IN SCHIZOPHRENIA
    MORSTYN, R
    DUFFY, FH
    MCCARLEY, RW
    ARCHIVES OF GENERAL PSYCHIATRY, 1983, 40 (07) : 729 - 734
  • [25] VENTRICLE SIZE AND P300 IN SCHIZOPHRENIA
    JUCKEL, G
    REISCHIES, FM
    MULLERSCHUBERT, A
    VOGEL, AC
    GAEBEL, W
    HEGERL, U
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1994, 243 (06) : 352 - 354
  • [26] Is the P300 wave an endophenotype for schizophrenia?
    Bramon, E
    McDonald, C
    Schoenberg, P
    Sham, P
    Frangou, S
    Murray, RM
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 53 - 54
  • [27] P300 and thought disorder in schizophrenia
    Iwanami, A
    Araki, T
    Otani, T
    Furukawa, S
    Kamio, S
    Fukuda, R
    Kasai, K
    Nakagome, K
    Fukuda, M
    Kato, N
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 126S - 126S
  • [28] Auditory and visual P300 in schizophrenia
    Vohs, JL
    Bodkins, M
    Bismark, A
    O'Donnell, BF
    Shekhar, A
    Hetrick, WP
    PSYCHOPHYSIOLOGY, 2004, 41 : S34 - S34
  • [29] Schizophrenia: The broken P300 and beyond
    Ford, JM
    PSYCHOPHYSIOLOGY, 1999, 36 (06) : 667 - 682
  • [30] P300 - A BIOLOGICAL MARKER OF SCHIZOPHRENIA
    DUNCAN, CC
    DARRELL, GK
    PSYCHOPHYSIOLOGY, 1987, 24 (05) : 587 - 587